Levetiracetam Stada (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a key role in neurotransmitter release. This binding modulates vesicle exocytosis, leading to decreased neuronal hyper‑excitability and a lower likelihood of seizure propagation.

The dose of Levetiracetam Stada is individualized by the prescribing clinician based on the patient’s age, renal function, seizure type, and response to therapy. Dosage adjustments are made to achieve optimal seizure control while minimizing adverse effects.

Levetiracetam is classified as a pregnancy category with limited data; its safety is not fully established. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with many traditional antiepileptics, levetiracetam has a relatively simple pharmacokinetic profile, few drug‑enzyme interactions, and does not require routine therapeutic drug monitoring. Its efficacy across multiple seizure types makes it a common alternative to drugs such as carbamazepine or valproate, especially when drug‑interaction risk is a concern.

Levetiracetam Stada should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain stability and potency.

Levetiracetam Stada is administered orally, typically as a tablet swallowed with water. The exact dosing schedule—once daily, twice daily, or more—depends on the prescriber’s assessment of the patient’s seizure pattern and renal function.

Serious risks include severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, and neuropsychiatric events including suicidal thoughts or aggressive behavior. Patients should seek immediate medical attention if they experience rash, swelling, mood changes, or any signs of an allergic reaction.

Levetiracetam Stada is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment who cannot be appropriately dose‑adjusted, and for those with a history of serious psychiatric disorders unless closely monitored.